Keywords: novartis, certican, delayed, usa, swiss, drug, major

Novartis' Certican delayed in USA

Article | 06 September 2004

Print This

Swiss drug major Novartis says it has received an approvable letterfrom the US Food and Drug Administration for Certican (everolimus) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in